-
Benchmark Reports Columbia Labs' Q4 Pro-Forma Beats Forecasts
Friday, March 11, 2011 - 8:25am | 145Read More...In a report published by Benchmark, Columbia Laboratories' (NASDAQ: CBRX) Q4 pro-forma beats forecasts but the focus remains on study data publication and NDA Filing. Benchmark said that Columbia reported Q4 results that were slightly better than anticipated but its focus remains Management's...
-
Coverage Initiated For Columbia Labs
Tuesday, October 5, 2010 - 10:39am | 25Read More...The Benchmark Company has initiated coverage for Columbia Labs (NASDAQ: CBRX) at Buy with a $3 price target.
